Diagnostic tests and prognostic indicators
Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy. Mathis S et al. Cytometry B Clin Cytom. 2014 Oct 28. doi: 10.1002/cytob.21200. [Epub ahead of print]. Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of…